Veracyte
VCYT
88 hedge funds and large institutions have $187M invested in Veracyte in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 41 increasing their positions, 23 reducing their positions, and 9 closing their positions.
78% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 23
57% more call options, than puts
Call options by funds: $1.42M | Put options by funds: $901K
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
5% more funds holding
Funds holding: 84 → 88 (+4)
2.57% more ownership
Funds ownership: 63.66% → 66.23% (+2.6%)
6% less capital invested
Capital invested by funds: $198M → $187M (-$11M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| 1 |
BlackRock
New York
|
+$2.76M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.34M |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$1.95M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$841K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$641K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$1.77M |
| 2 |
BC
Broadfin Capital
New York
|
-$1.65M |
| 3 |
Two Sigma Investments
New York
|
-$712K |
| 4 |
PCM
Prelude Capital Management
New York
|
-$582K |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$467K |
VCYT Hedge Fund Activity: Q2 2017 in Review
88 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2017, worth a combined $187M — down 5.5% from $198M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new VCYT positions and 9 closed out — a net gain of 4 holders — while 41 added to existing stakes and 23 trimmed.
The largest buyer was BlackRock, adding an estimated $2.76M. The largest seller was Millennium Management, cutting an estimated $1.77M.
- 88 institutional investors held Veracyte (VCYT) as of Q2 2017, up from 84 in Q1 2017.
- Funds reported $187M of Veracyte stock for Q2 2017, down 5.5% quarter-over-quarter.
- 13 funds opened new Veracyte positions in Q2 2017 and 9 closed out, a net change of +4 holders.
- The largest Veracyte buyer in Q2 2017 was BlackRock, an estimated $2.76M added.
- The largest Veracyte seller in Q2 2017 was Millennium Management, an estimated $1.77M sold.
Based on aggregated 13F filings for Q2 2017.